Clinical trials
Observational Metabolic Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Unknown status | 5 |
| Completed | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Groupe Hospitalier Pitie-Salpetriere | 2 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Shire | 1 |
| University Hospital, Angers | 1 |
| University Hospital, Bordeaux | 1 |
| University Hospital, Grenoble | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 16 |
| Diabetes Mellitus | 3 |
| Heart Diseases | 3 |
| Cardiovascular Diseases | 2 |
| Drug-Related Side Effects and Adverse Reactions | 2 |
| Obesity | 2 |
| Acute Kidney Injury | 1 |
| Atherosclerosis | 1 |
| Brain Diseases | 1 |
| Brain Diseases, Metabolic, Inborn | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.